WallStreetZenWallStreetZen

NASDAQ: CTNM
Contineum Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Contineum Therapeutics revenue was N/A for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CTNM annual revenue was $50.0M, with Infinity% growth year-over-year.

CTNM revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when CTNM announces revenue.

CTNM Revenue History By Year

CTNM Yearly RevenueCTNM RevenueCTNM ChangeCTNM Revenue Growth
2023-12-31$50.00MN/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Contineum Therapeutics Revenue FAQ

What was CTNM's revenue last quarter?

Contineum Therapeutics (NASDAQ: CTNM) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Contineum Therapeutics's revenue was $0.00.

What was Contineum Therapeutics's revenue in 2023?

Contineum Therapeutics's annual revenue for the twelve months ending Dec 31, 2023 was $50.00 million, a Infinity% increase year over year.

How much does Contineum Therapeutics make in a day?

Based on Contineum Therapeutics annual revenue for the past one years, CTNM makes an average of $136,986.30 per day.

What was Contineum Therapeutics's annual revenue growth in the past year?

As of Q4 2024, Contineum Therapeutics's revenue has grown null year over year. Contineum Therapeutics's revenue in the past year totaled N/A.

How much does Contineum Therapeutics make in a year?

Contineum Therapeutics's revenue by year for the past one years is:
  • Contineum Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $50.00 million, a Infinity% increase year over year.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.